0000899243-21-017111.txt : 20210427 0000899243-21-017111.hdr.sgml : 20210427 20210427170137 ACCESSION NUMBER: 0000899243-21-017111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210427 FILED AS OF DATE: 20210427 DATE AS OF CHANGE: 20210427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vellanki Avanish CENTRAL INDEX KEY: 0001856682 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40356 FILM NUMBER: 21859846 MAIL ADDRESS: STREET 1: 8000 JARVIS AVENUE STREET 2: SUITE 204 CITY: NEWARK STATE: CA ZIP: 94560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rain Therapeutics Inc. CENTRAL INDEX KEY: 0001724979 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821130967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 JARVIS AVENUE STREET 2: SUITE 204 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: (510) 953-5559 MAIL ADDRESS: STREET 1: 8000 JARVIS AVENUE STREET 2: SUITE 204 CITY: NEWARK STATE: CA ZIP: 94560 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-27 0 0001724979 Rain Therapeutics Inc. RAIN 0001856682 Vellanki Avanish C/O RAIN THERAPEUTICS INC. 8000 JARVIS AVENUE, SUITE 204 NEWARK CA 94560 1 1 0 0 President and CEO Common Stock 2021-04-27 4 C 0 11212 A 2372541 D Common Stock 138901 I By Trust Series A Preferred Stock 2021-04-27 4 C 0 12108 0.00 D Common Stock 11212 0 D The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-1.0799 basis upon the closing of the Issuer's initial public offering and had no expiration date. /s/ Nelson Cabatuan, Attorney-in-fact for Avanish Vellanki 2021-04-27